BioCentury
ARTICLE | Company News

Cephalon, Chiron sales and marketing update

August 5, 1996 7:00 AM UTC

The companies started registration for an expanded access program to make limited supplies of Myotrophin IGF-1 available in the U.S. to patients with amyotrophic lateral sclerosis. The National Organ...